secwatch.observer — SEC 8-K summary
======================================

Issuer:     Coherus Oncology, Inc. (CHRS)
CIK:        0001512762
Form:       8-K/A
Filed at:   2023-11-13T23:59:59+00:00
Accession:  0001193125-23-275207
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.50
Item codes: 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Coherus completes Surface Oncology acquisition, files Surface's financials on 8-K/A
--------------------------------------------------------------------------------

- Merger closed Sep 8, 2023; Surface became wholly owned subsidiary after two-step merger.
- Unaudited condensed financial statements of Surface for H1 2023 and 2022 now filed on this amendment.
- Financial statements incorporated from Surface's Q2 2023 10-Q filed Aug 2, 2023.
- Original 8-K filed Sep 8, 2023 reported the closing; this amendment adds required financials.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1512762/000119312523275207/0001193125-23-275207-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1512762/000119312523275207/d514976d8ka.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-275207

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer